PDF(Pubmed)
Abstract：
UNASSIGNED: To describe the demographics and clinical profile of patients with glaucoma presenting during the novel coronavirus (COVID-19) lockdown and unlock phases in India.
UNASSIGNED: This retrospective hospital-based comparative study included patients presenting between March 25, 2017, and March 31, 2021. All patients who presented with glaucoma disorders were included as cases. The demographic and clinical data of these glaucoma patients were collected using an electronic medical record system.
UNASSIGNED: Overall, 34,419 patients (mean 47 per day) diagnosed with glaucoma diseases presented to the network and were included for analysis. The mean age of the patients was 54.16 ± 18.74 years and most were male (n=21,140; 61.42%) from the urban region (n=12,871;37.4%). On categorizing based on the timeline of the COVID-19 pandemic, most of the patients presented pre-COVID-19 (n=29,122; 84.61%), followed by a minority (n=175; 0.51%) during the lockdown and the rest (n=5,122; 14.88%) during unlock phase. An increasing number of patients with secondary glaucoma (n=82; 46.86%) and presenting from the local intra-city (n=82; 46.86%) was seen during the lockdown. There was a 6.6-fold increase in neovascular glaucoma and a 2.7-fold increase in lens induced glaucoma during the lockdown phase ((p<0.001) for both). There was a significant increase in subjects in 4th decade (p<0.03) and a decrease in subjects in 7th decade (p<0.008) during the lockdown period.
UNASSIGNED: The presentation of patients with glaucoma disorders to the hospital is evolving due to the COVID-19 pandemic. The footfalls of patients during the unlock regained to two-thirds of the pre COVID-19 level. During the lockdown, the older patients were less, there was an increase in younger patients and those with secondary glaucoma, and the majority presenting from within the city.
UNASSIGNED: This retrospective hospital-based comparative study included patients presenting between March 25, 2017, and March 31, 2021. All patients who presented with glaucoma disorders were included as cases. The demographic and clinical data of these glaucoma patients were collected using an electronic medical record system.
UNASSIGNED: Overall, 34,419 patients (mean 47 per day) diagnosed with glaucoma diseases presented to the network and were included for analysis. The mean age of the patients was 54.16 ± 18.74 years and most were male (n=21,140; 61.42%) from the urban region (n=12,871;37.4%). On categorizing based on the timeline of the COVID-19 pandemic, most of the patients presented pre-COVID-19 (n=29,122; 84.61%), followed by a minority (n=175; 0.51%) during the lockdown and the rest (n=5,122; 14.88%) during unlock phase. An increasing number of patients with secondary glaucoma (n=82; 46.86%) and presenting from the local intra-city (n=82; 46.86%) was seen during the lockdown. There was a 6.6-fold increase in neovascular glaucoma and a 2.7-fold increase in lens induced glaucoma during the lockdown phase ((p<0.001) for both). There was a significant increase in subjects in 4th decade (p<0.03) and a decrease in subjects in 7th decade (p<0.008) during the lockdown period.
UNASSIGNED: The presentation of patients with glaucoma disorders to the hospital is evolving due to the COVID-19 pandemic. The footfalls of patients during the unlock regained to two-thirds of the pre COVID-19 level. During the lockdown, the older patients were less, there was an increase in younger patients and those with secondary glaucoma, and the majority presenting from within the city.
摘要：
■描述印度新型冠状病毒（COVID-19）锁定和解锁阶段出现的青光眼患者的人口统计学和临床特征。
这项以医院为基础的回顾性比较研究包括2017年3月25日至2021年3月31日期间的患者。所有出现青光眼疾病的患者均包括在内。使用电子病历系统收集这些青光眼患者的人口统计学和临床数据。
■总的来说，34,419名诊断为青光眼疾病的患者（平均每天47名）提交给网络，并纳入分析。患者的平均年龄为54.16±18.74岁，大多数为男性（n=21,140;61.42％），来自城市地区（n=12,871;37.4％）。在根据COVID-19大流行的时间表进行分类时，大多数患者出现COVID-19之前（n=29,122；84.61%），其次是少数（n=175；0.51％）在锁定阶段，其余（n=5,122；14.88％）在解锁阶段。在封锁期间，看到越来越多的继发性青光眼患者（n=82；46.86％）和来自当地市内的患者（n=82；46.86％）。在锁定阶段，新生血管性青光眼增加了6.6倍，晶状体诱导的青光眼增加了2.7倍（（p<0.001））。在禁闭期间，第4个十年的受试者人数显着增加（p<0.03），第7个十年的受试者人数减少（p<0.008）。
■由于COVID-19大流行，青光眼疾病患者到医院就诊的情况正在演变。解锁期间患者的脚步恢复到COVID-19前水平的三分之二。在封锁期间,老年患者较少，年轻患者和继发性青光眼患者有所增加，大多数人来自城市内部。
这项以医院为基础的回顾性比较研究包括2017年3月25日至2021年3月31日期间的患者。所有出现青光眼疾病的患者均包括在内。使用电子病历系统收集这些青光眼患者的人口统计学和临床数据。
■总的来说，34,419名诊断为青光眼疾病的患者（平均每天47名）提交给网络，并纳入分析。患者的平均年龄为54.16±18.74岁，大多数为男性（n=21,140;61.42％），来自城市地区（n=12,871;37.4％）。在根据COVID-19大流行的时间表进行分类时，大多数患者出现COVID-19之前（n=29,122；84.61%），其次是少数（n=175；0.51％）在锁定阶段，其余（n=5,122；14.88％）在解锁阶段。在封锁期间，看到越来越多的继发性青光眼患者（n=82；46.86％）和来自当地市内的患者（n=82；46.86％）。在锁定阶段，新生血管性青光眼增加了6.6倍，晶状体诱导的青光眼增加了2.7倍（（p<0.001））。在禁闭期间，第4个十年的受试者人数显着增加（p<0.03），第7个十年的受试者人数减少（p<0.008）。
■由于COVID-19大流行，青光眼疾病患者到医院就诊的情况正在演变。解锁期间患者的脚步恢复到COVID-19前水平的三分之二。在封锁期间,老年患者较少，年轻患者和继发性青光眼患者有所增加，大多数人来自城市内部。
